Home › Categories › Business & Finance› 事業計画及び� �長可能性に関� ��る事項

事業計画及び� �長可能性に関� ��る事項.pdf

140120221223583007.pdf

🔗 Source: www2.jpx.co.jp

📊 Size: 6.23 MB

👤 Author: Adachi

⬇️ Downloads: 167

Summary

Kringle Pharma, Inc. is a Japanese biotech company established in 2001, focused on researching, developing, manufacturing, and selling HGF (hepatocyte growth factor) as a pharmaceutical product. The company's vision is to contribute to society by providing innovative treatments for intractable diseases. Their management team consists of experienced professionals, including CEO Katsuaki Adachi, who has been with the company since 2004. The company has several products in development, including treatments for spinal cord injuries, vocal cord scarring, and amyotrophic lateral sclerosis (ALS). Kringle Pharma aims to grow through expanding its product lineup and adapting to changing market conditions.

Download File

Description

Kringle Pharma, Inc.

Technical Information

File Format: PDF
File Size: 6.23 MB
Pages: 72
Language: EN
Author: Adachi
Total Downloads: 167
Last Updated: 2 weeks ago

Document Overview

This PDF document about 事業計画及び� �長可能性に関� ��る事項 provides comprehensive information and guidance. Whether you're a beginner or advanced user, this resource offers valuable insights into 事業計画及び� �長可能性に関� ��る事項.